Pension Fund v. Watson Pharmaceutica ( 2007 )


Menu:
  •                      FOR PUBLICATION
    UNITED STATES COURT OF APPEALS
    FOR THE NINTH CIRCUIT
    EMPLOYERS-TEAMSTERS LOCAL NOS.              
    175 & 505 PENSION TRUST FUND,
    INTERNATIONAL UNION OF
    OPERATING ENGINEERS, LOCAL 132
    PENSION PLAN, and WEST VIRGINIA
    LABORERS’ PENSION TRUST FUND,                     No. 04-56791
    Pension-Fund Plaintiffs-                  D.C. Nos.
    Appellants,              CV-03-08236-AHM
    v.                             CV-03-08946-AHM
    CV-03-09291-AHM
    ANCHOR CAPITAL ADVISORS,
    CV-03-09628-AHM
    Lead Plaintiff-Appellee,
    OPINION
    and
    WATSON PHARMACEUTICALS, INC.,
    ALLEN CHAO, JOSEPH C. PAPA, FRED
    WILKINSEN, and MICHAEL E. BOXER,
    Defendants-Appellees.
    
    Appeal from the United States District Court
    for the Central District of California
    A. Howard Matz, District Judge, Presiding
    Argued and Submitted
    November 17, 2006—Pasadena, California
    Filed August 16, 2007
    Before: Thomas G. Nelson and Jay S. Bybee, Circuit Judges,
    and Kevin Thomas Duffy,* District Judge.
    *The Honorable Kevin Thomas Duffy, Senior Judge, United States
    District Court for the Southern District of New York, sitting by designa-
    tion.
    9973
    9974 EMPLOYERS-TEAMSTERS v. WATSON PHARMACEUTICALS
    Opinion by Judge Duffy
    EMPLOYERS-TEAMSTERS v. WATSON PHARMACEUTICALS 9975
    COUNSEL
    Joseph D. Daley, Esq., William S. Lerach, Esq., Darren J.
    Robbins, Esq., Eric Alan Isaacson, Esq., Daniel S. Drosman,
    Esq., Lerach Coughlin Stoia Geller Rudman & Robbins LLP,
    for appellant Pension Fund.
    Christopher Kim, Esq., Lisa J. Yang, Esq., Lim Ruger and
    Kim, for lead plaintiff-appellee Anchor Capital Advisors.
    9976 EMPLOYERS-TEAMSTERS v. WATSON PHARMACEUTICALS
    Sean M. Handler, Esq., Stuart L. Berman, Esq., Robin Win-
    chester, Esq., Schiffrin & Barroway, LLP, for lead plaintiff-
    appellee Anchor Capital Advisors.
    Seth Aronson, Esq., Robert C. Vanderet, Esq., David I. Hur-
    witz, Esq., J. Cacilia Kim, Esq., O’Melveny & Myers LLP,
    for defendants-appellees Watson Pharmaceuticals, Inc., Allen
    Chao, Joseph C. Papa, Fred Wilkinson, and Michael E. Boxer.
    OPINION
    DUFFY, District Judge:
    Appellants, non-parties to the action below, bring this
    appeal from the district court’s order granting lead plaintiff’s
    motion to dismiss its claims in an uncertified securities class
    action. Because Appellants never filed a complaint or for-
    mally moved to intervene, they lack standing and we are
    therefore precluded from reaching the merits of Appellants’
    argument that they would have been the proper lead plaintiff
    pursuant to the Private Securities Litigation Reform Act (the
    “PSLRA”), 15 U.S.C. § 78u-4(a). Furthermore, lead plain-
    tiff’s voluntary dismissal of its claims prior to class certifica-
    tion renders this appeal of the interim lead plaintiff order
    moot. Appellants’ argument that they could not file their own
    complaint due to the proscription against “piggybacking” on
    an original class action is also without merit. The appeal is
    dismissed.
    I.   Facts
    On November 12, 2003, Anchor Capital Advisors (“Anchor
    Capital”) filed the first of four purported class actions in the
    Central District of California against Watson Pharmaceuti-
    cals, Inc. (“Watson Pharmaceuticals”) for alleged violations
    of Sections 10(b) and 20(a) of the Securities Exchange Act of
    EMPLOYERS-TEAMSTERS v. WATSON PHARMACEUTICALS 9977
    1934. Appellants did not file a complaint or move to intervene
    in any of the four district court actions. On February 9, 2004,
    the district court consolidated the four actions and considered
    the motions of various parties, including Appellants’, for
    appointment of lead plaintiff pursuant to the PSLRA. The dis-
    trict court preliminarily declared Anchor Capital as the lead
    plaintiff based upon its loss of $3.2 million on behalf of its
    investors, holding that it had sufficient authority to sue on
    behalf of its clients and that it was the party with the largest
    financial stake in the outcome of the litigation.1
    Watson Pharmaceuticals moved to dismiss the complaint
    for failure to plead fraud with the particularity required by
    Fed.R.Civ.P. 9(b) and the PSLRA. On August 2, 2004, the
    district court dismissed the complaint for failure to adequately
    plead falsity and scienter. The order allowed Anchor Capital
    the opportunity to re-plead, however, held that it would be
    “unlikely that Plaintiffs will be able to amend to allege addi-
    tional facts that will satisfy the heightened pleading require-
    ments.” See Order Granting Motion to Dismiss the
    Consolidated Complaint, August 2, 2004, at 27. In light of
    this ruling, Anchor Capital informed the district court that it
    would not file another amended complaint, instead requesting
    that the individual uncertified actions be dismissed with preju-
    dice. Appellants did not object to the dismissal or take any
    1
    Appellants argue that an investment advisor such as Anchor Capital
    cannot be the appropriate lead plaintiff because it did not have express
    written authority to sue on its clients’ behalf, a requirement articulated by
    some—but not all—of the district courts that have weighed in on this
    issue. See, e.g., Kaplan v. Gelfond, 
    240 F.R.D. 88
     (S.D.N.Y. 2007); Smith
    v. Suprema Specialties, Inc., 
    206 F. Supp. 2d 627
    , 634-35 (D.N.J. 2002).
    On the other hand, as the district court found here, other courts have found
    that an investment advisor has an interest in its own right to receive full
    and fair disclosures regarding the true value of a company’s stock, and
    therefore is a “purchaser” under the PSLRA with proper standing to pur-
    sue litigation on behalf of its individual clients. See, e.g., Lehocky v. Tidel
    Technologies, Inc., 
    220 F.R.D. 491
    , 501 (S.D. Tex. 2004); In re Rent-Way
    Litig., 
    218 F.R.D. 101
    , 109 (W.D. Pa. 2003).
    9978 EMPLOYERS-TEAMSTERS v. WATSON PHARMACEUTICALS
    other action at that time. Accordingly, on September 2, 2004,
    the district court dismissed the action with prejudice. On
    appeal, Appellants now challenge the lead plaintiff ruling.
    II.        Discussion
    a.    Standing
    [1] Standing is the threshold issue of any federal action, a
    matter of jurisdiction because “the core component of stand-
    ing is an essential and unchanging part of the case-or-
    controversy requirement of Article III.” See Lujan v. Defend-
    ers of Wildlife, 
    504 U.S. 555
    , 561 (1992). In this case,
    because the class was never certified, Appellants were not
    parties to the district court action and lack standing to bring
    this appeal. Appellants were merely potential class members
    in a potential class action suit. Despite ample opportunity to
    do so, Appellants never filed a complaint, moved to intervene,
    objected to the requested dismissal, or filed an amended com-
    plaint after Anchor Capital notified the district court that it
    would voluntarily dismiss its action. As articulated in Marino
    v. Ortiz “only parties to a lawsuit, or those that properly
    become parties, may appeal an adverse judgment.” Marino v.
    Ortiz, 
    484 U.S. 301
    , 304 (1988).
    Notwithstanding this principle, the main thrust of Appel-
    lant’s argument is premised on Z-Seven Fund, which holds
    that a class member must await final judgment before it is
    permitted to appeal from a lead-plaintiff ruling. See Z-Seven
    Fund v. Motorcar Parts & Accessories, 
    231 F.3d 1215
    , 1218-
    19 (9th Cir. 2000). Appellants attempt to stretch the holding
    of Z-Seven to imply that even putative members of a non-
    certified class have standing to appeal a lead-plaintiff ruling
    after judgment of dismissal has been entered. In light of
    Marino, this cannot be the case.
    [2] The denial of Appellants’ lead-plaintiff motion did not
    leave them without a remedy. Most intuitive among their host
    EMPLOYERS-TEAMSTERS v. WATSON PHARMACEUTICALS 9979
    of options was to file a motion for intervention. Appellants
    incorrectly argue that a motion for intervention would have
    served no purpose after their lead-plaintiff motion was denied.
    The standards governing motions for intervention and for lead
    plaintiff status, however, could not be more different. At the
    relevant time, permissive intervention merely required that:
    [u]pon timely application anyone may be permitted
    to intervene in an action: (1) when a statute of the
    United States confers a conditional right to inter-
    vene; or (2) when an applicant’s claim or defense
    and the main action have a question of law or fact in
    common . . . . In exercising its discretion the court
    shall consider whether the intervention will unduly
    delay or prejudice the adjudication of the rights of
    the original parties.
    See F.R.C.P. 24(b), amended by 2007 U.S. Order 07-30
    (applying non-substantive changes to the requirements for
    permissive intervention). On the other hand, a motion for lead
    plaintiff status carries with it a more onerous burden: indeed,
    the substance of this appeal is premised on the ability to prove
    which prospective lead plaintiff is the most adequate by virtue
    of having the highest financial stake in the outcome of the
    case.
    [3] Appellants argue that their motion for lead plaintiff sta-
    tus was tantamount to a motion for intervention. This is sim-
    ply not so. The plain language of the PSLRA states that:
    Not later than 90 days after the date on which a
    notice is published under subparagraph (A)(i), the
    court shall consider any motion made by a purported
    class member in response to the notice, including
    any motion by a class member who is not individu-
    ally named as a plaintiff in the complaint or com-
    plaints, and shall appoint as lead plaintiff the
    member or members of the purported plaintiff class
    9980 EMPLOYERS-TEAMSTERS v. WATSON PHARMACEUTICALS
    that the court determines to be most capable of ade-
    quately representing the interests of class members
    ....
    See 15 U.S.C. § 78u-4(a)(3)(B)(i). The plain language of this
    statute is testament to the fact that a motion to be appointed
    as lead plaintiff is not the same as a formal motion to inter-
    vene. Appellants cite three cases in an unsuccessful attempt
    to bolster their argument. See Griffin v. Paine Webber Inc., 
    84 F. Supp. 2d 508
    , 514 (S.D.N.Y. 2000); In re Lucent Techs.
    Inc. Sec. Litig., 
    194 F.R.D. 137
    , 146 (D.N.J. 2000); Ravens v.
    Iftikar, 
    174 F.R.D. 651
    , 659 (N.D. Cal. 1997). These cases
    describe the purposes and procedures of obtaining lead plain-
    tiff status pursuant to the PSLRA; however, none of these
    cases stand for the proposition that simply making this motion
    dispenses with the necessity of formally intervening.2
    [4] In the alternative, Appellants cite Devlin v. Scardelletti
    to argue that a non-named class member who fails to properly
    intervene may nevertheless bring an appeal after a settlement
    2
    Appellants do not argue or explain why they believe these cases stand
    for their position, instead choosing to rely on a single statement in Ravens
    to support their argument: “the central purpose [of the lead-plaintiff notice
    requirement] is to enable the member of the putative class with the ‘largest
    financial interest in the relief sought by the class’ to make a rational deci-
    sion whether to intervene.” See Ravens, 174 F.R.D. at 659. To be sure, the
    notice requirement of the PSLRA is designed to ensure that the most ade-
    quate plaintiff emerges to the position of representing the class. For this
    goal to be achieved, it is necessary that all interested parties are informed
    of their host of options, which include making a motion for lead plaintiff
    status, opting out, and making a motion for intervention, among other
    things. We do not think the language to which Appellants point, standing
    alone, is enough to equate a motion for lead-plaintiff status under the
    PSLRA with a formal motion for intervention. Indeed, in Ravens the court
    went on to say that, “[u]nder Congress’ regime, qualified investors must
    decide whether to intervene or compete for lead plaintiff appointment and
    to negotiate attorney arrangements so that the class representative that
    emerges is the ‘most capable of adequately representing the interests of
    the class.’ ” Id. at 676 (emphasis added).
    EMPLOYERS-TEAMSTERS v. WATSON PHARMACEUTICALS 9981
    agreement has been entered. See Devlin v. Scardelletti, 
    536 U.S. 1
    , 6 (2002). This case is easily distinguishable. In Devlin
    the class had been certified, and therefore the non-named
    plaintiffs had standing to appeal, much like in Z-Seven. In this
    case, on the other hand, the appellants were not members of
    a certified class and therefore lack standing to appeal any
    judgment in the case below.
    b.   Mootness
    [5] Appellee’s voluntary dismissal of their claims before
    the putative class was certified renders the appeal of the
    interim lead plaintiff order moot. “[A] suit brought as a class
    action must as a general rule be dismissed for mootness when
    the personal claims of all named plaintiffs are satisfied and no
    class has been properly certified.” See Zeidman v. J. Ray
    McDermott & Co., Inc., 
    651 F.2d 1030
    , 1045 (5th Cir. 1981).
    In these situations there is no longer a ‘case or controversy’
    to be decided within the meaning of Article III of the Consti-
    tution.
    c.   The Filing of an Additional Claim Would Not Have
    Been Impermissible “Piggybacking”
    [6] In American Pipe, the Court held that the commence-
    ment of an original class suit tolls the running of the statute
    of limitations for all purported members of the class until
    class certification is denied. See American Pipe & Constr. Co.
    v. Utah, 
    414 U.S. 538
    , 553 (1974). At that point, “class mem-
    bers may choose to file their own action or to intervene as
    plaintiffs in the pending action.” Crown, Cork & Seal Co.,
    Inc. v. Parker, 
    462 U.S. 345
    , 354 (1983). In this case, when
    the litigation clock again began to run the Appellants were
    afforded a one-day opportunity to file their own complaint.
    This time constraint was, of course, due to the original action
    having been filed only one day before the statute of limita-
    tions expired. This fact was known to the parties and their
    supposedly sophisticated counsel, and they should have made
    9982 EMPLOYERS-TEAMSTERS v. WATSON PHARMACEUTICALS
    arrangements to be able to file their own action in a limited
    time period if necessity required.
    [7] There is case law suggesting that Appellants would
    have been precluded from filing another class action. See
    Robbin v. Fluor Corp., 
    835 F.2d 213
    , 213 (9th Cir. 1987). It
    is also possible, however, that this rule only applies when the
    appropriateness of the class action has been previously
    rejected. See Korwek v. Hunt, 
    827 F.2d 874
    , 879 (2d Cir.
    1987) (“the tolling doctrine enunciated in American Pipe does
    not apply to permit a plaintiff to file a subsequent class action
    following a definitive determination of the inappropriateness
    of class certification.”)(emphasis added). Here the appropri-
    ateness of a class action was never examined; instead the case
    was voluntarily dismissed before the class was certified.
    Regardless of whether Appellants would have been permitted
    to file another class action, however, one thing remains clear:
    the “piggybacking” prohibition would have in no way pre-
    cluded them from filing their own individual action.
    The argument that there was no time to file a new com-
    plaint is also without merit. Appellants had ample opportunity
    to file a motion for intervention throughout the pendency of
    the original class action. Had they successfully intervened,
    Appellants would have been parties and would have had
    standing to appeal the lead-plaintiff order. Furthermore,
    Appellants had a one-day window to file their own complaint
    after the action was dismissed. While Appellants were admit-
    tedly confined to a limited time frame, they are a sophisti-
    cated party who was on notice of the situation and should
    have been prepared to file a complaint when and if the action
    was dismissed.
    It is also worth noting that there is no evidence to suggest
    that Appellants would have filed their own complaint initially.
    While the PSLRA may have been drafted to avoid “hurried,
    ill-researched    complaints,”     see    Plaintiffs-Appellants’
    Response to Order to Show Cause at 9, this statute certainly
    EMPLOYERS-TEAMSTERS v. WATSON PHARMACEUTICALS 9983
    was not intended to allow parties to benefit from tolling when
    they would not have filed a complaint in the first place. This
    statute was also certainly not intended to excuse sophisticated
    parties from being diligent and keeping abreast of develop-
    ments in the case, especially when the class is not certified.
    III.   Conclusion
    Appellants lack standing to bring this appeal. The appeal is
    DISMISSED.